Mark Carroll

Mark Carroll has over 26 years of work experience in the pharmaceutical and healthcare industry. Currently, they are serving as the VP, Head of Quality and Compliance at BioXcel Therapeutics Inc. Mark joined the company in March 2019 and continues to hold this position. From 2012 to 2019, Mark worked as the VP of Quality Assurance and Regulatory Affairs at Agile Therapeutics. Prior to that, they were employed at Luitpold Pharmaceuticals as the Director of Quality Assurance from 2009 to 2012. In 2008, they briefly worked as the Director of Pharmaceutical Quality at Alpharma before its acquisition. Before that, Mark held the position of Director of Quality Assurance at ICON plc from 2004 to 2008. From 2002 to 2004, they worked as the Corporate Audit and Compliance Manager at Schering-Plough, where they conducted GXP audits in accordance with regulatory guidelines. Mark also worked as the Manager of Quality and Regulatory Affairs at Scapa North America from 1998 to 2002, and as the Quality Systems Manager at Akzo Nobel Coatings from 1995 to 1998. Mark started their career as an Associate Chemist at HB Fuller in 1993. Overall, their extensive experience includes leadership roles in quality assurance, regulatory affairs, and compliance in various organizations within the pharmaceutical industry.

Mark Carroll received a Bachelor's degree in Chemistry from Stockton University, which they attended from 1987 to 1993. In 1995, they enrolled in the New York University - Polytechnic School of Engineering, where they pursued a Master of Science (MS) degree in Management of Technology. Mark completed their master's program in 1997.